Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 |
| clinicaltrials |
| NCT00650988 | Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers | completed | Early Phase 1 | 37 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00525200 | p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer(PANCHO) | completed | Phase 3 | 170 | Daniela KandiolerOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00003076 | Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus | completed | Phase 2 | 152 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT01341197 | Fecal Screening Assay for Taiwanese Population | completed | — | 3,172 | National Taiwan University HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01243398 | Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy | completed | Phase 3 | 450 | University of OxfordOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01391208 | Esophageal Protocol for Detection of Neoplasia in the Digestive Tract | completed | Phase 1 | 25 | University of MichiganOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00798746 | Quality of Life After Esophagectomy for Cancer | completed | — | 88 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00006081 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00505024 | Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery | completed | N/A | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00502502 | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | completed | — | 205 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01640860 | Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer | completed | — | 36 | Chonnam National University HospitalOTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT01038544 | Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer(CT0003) | completed | N/A | 50 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00012363 | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus | completed | Phase 2 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00445861 | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00072033 | Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | completed | Phase 2 | 66 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00238407 | Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 21 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | completed | Phase 1 / Phase 2 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT01605305 | Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 60 | Fudan UniversityOTHER | 0 | May 24, 2012 | clinicaltrials |
| NCT00520091 | Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | completed | Phase 2 | 14 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00017212 | DX-8951f in Treating Patients With Metastatic Stomach Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 2 | May 16, 2012 | clinicaltrials |
| NCT00753844 | Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer | completed | Phase 1 | 7 | Kinki UniversityOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | completed | Phase 1 | 12 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | completed | Phase 1 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00900094 | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer(IRB 2000-294) | completed | — | 200 | University of Michigan Rogel Cancer CenterOTHER | 0 | Feb 7, 2012 | clinicaltrials |
| NCT01525953 | Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis(CRCRT-EC) | completed | — | 110 | Centre Oscar LambretOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT00002935 | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer | completed | Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT00665197 | Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia | completed | Phase 3 | 200 | International Atomic Energy AgencyOTHER_GOV | 7 | Oct 13, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00051480 | Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00497549 | Trial Comparing Side-to-Side Stapled and Hand-sewn Esophagogastric Anastomosis in Neck | completed | N/A | 174 | All India Institute of Medical SciencesOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00578201 | FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer(FOLFOX) | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 31, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00060268 | Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors | completed | Phase 1 / Phase 2 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 9, 2011 | clinicaltrials |
| NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma(EXCEL) | completed | Phase 2 | 55 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01269970 | Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy | completed | — | — | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT01170845 | Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy(NEIE) | completed | N/A | 31 | Yokohama City University Medical CenterOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00583934 | Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial? | completed | — | 19 | University of California, DavisOTHER | 1 | Jul 13, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | completed | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01032967 | Surgery or Chemoradiation for Esophageal Cancer | completed | Phase 3 | 40 | Chinese University of Hong KongOTHER | 0 | Dec 16, 2009 | clinicaltrials |
| NCT01033695 | Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes | completed | — | 74 | Odense University HospitalOTHER | 1 | Dec 16, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Jan 16, 2013source: clinicaltrials